You are here
The purpose of this costing study was to undertake an analysis of CALD patients to inform a policy decision for whether an adjustment is warranted to the National Efficient Price for CALD patients.
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
As prescribed in Section 225 of the National Health Reform Act 2011 (the Act), the objectives of the IHPA Work Program are to:
- set out IHPA’s work program for the coming year; and
- invite interested persons (including states and territories) to make submissions to the Pricing Authority about the work program up to 30 days after publication.
An extract of Section 225 of the Act is attached at Appendix 1.
The purpose of this report is to review the costs of providing care to Indigenous patients accessing public hospital services. This work was commissioned in response to stakeholder concerns that the national activity based funding system does not adequately reflect Indigenous patient costs.
The Independent Hospital Pricing Authority is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2015-16 National Efficient Cost Determination:
Home Enteral Nutrition, Home Total Parenteral Nutrition and Home Ventilation Services Costing Study Report16 January 2015
The Costing study on Home Enteral Nutrition, Home Total Parenteral Nutrition and Home Ventilation Services was undertaken in 2014. The purpose of the study was to review the costs associated with the delivery of public hospital services to patients receiving home enteral nutrition, home total parenteral nutrition and home ventilation services. The study include a literature review, stakeholder consultation and costing the respective services based on data collected from the jurisdictions.
The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this 2014-15 National Efficient Cost Determination (Determination):
(a) to determine the national efficient cost for health care services provided by public hospitals where the services are block funded;